Product Overview
Atorvatin is a pharmaceutical preparation containing Atorvastatin Calcium as its active component. Presented in tablet form for oral use, this medication falls under the statin class of drugs, primarily prescribed for cholesterol management. Atorvatin functions by inhibiting hepatic HMG-CoA reductase, a key enzyme in cholesterol synthesis, effectively reducing LDL (“bad”) cholesterol and triglyceride levels while elevating HDL (“good”) cholesterol. This mechanism contributes to decreased cardiovascular risk.
Therapeutic Applications
This medication is indicated for:
- Management of hypercholesterolemia (elevated blood cholesterol)
- Cardiovascular risk reduction in patients with coronary artery disease or diabetes
- Treatment of familial hypercholesterolemia (genetic cholesterol disorder)
- Prevention of atherosclerotic cardiovascular complications
Administration Guidelines
For optimal results:
- Take orally with water, with or without food
- Preferred administration time: evening
- Swallow tablets whole; do not crush or chew
- Maintain consistent dosing schedule
- If a dose is missed, take when remembered unless near next scheduled dose
Mechanism of Action
Atorvatin exerts its therapeutic effect through selective, competitive inhibition of hepatic HMG-CoA reductase. This action:
- Reduces endogenous cholesterol production
- Enhances hepatic LDL receptor activity
- Promotes clearance of circulating LDL particles
- Modestly increases HDL cholesterol concentrations
Dosage Protocol
Therapeutic regimen should be individualized based on:
- Baseline LDL-C levels
- Therapeutic goals
- Patient tolerance
Standard initial dosage ranges from 10-20 mg daily, with possible titration up to 80 mg daily based on therapeutic response and tolerability. Regular monitoring of lipid profiles and hepatic function is recommended during therapy.
Therapeutic Advantages
- Significant LDL-C reduction (up to 50-60% at maximal doses)
- Favorable effects on triglyceride metabolism
- HDL-C elevation potential
- Proven cardiovascular event reduction
- Once-daily dosing convenience
Adverse Effects
Common (≥1%) treatment-emergent effects include:
- Musculoskeletal discomfort
- Gastrointestinal disturbances
- Headache
Rare but serious potential effects requiring immediate medical attention:
- Hepatotoxicity (jaundice, dark urine)
- Myopathy/rhabdomyolysis (unexplained muscle pain)
- Hypersensitivity reactions
Important Precautions
- Contraindicated in pregnancy and lactation
- Exercise caution in hepatic impairment
- Avoid concurrent grapefruit consumption
- Monitor for glucose dysregulation in diabetics
- Assess CK levels if muscle symptoms occur
Storage Requirements
- Maintain at controlled room temperature (15-30°C)
- Protect from moisture and light
- Keep in original packaging until use
- Properly dispose of expired medication
Medical Disclaimer
The information provided herein is for educational purposes only and does not constitute medical advice. This content:
- Is not exhaustive regarding all possible effects
- Does not replace professional medical judgment
- Should be reviewed with a qualified healthcare provider
- Is intended to complement, not substitute, physician consultation
Always consult your prescribing physician regarding any medical concerns or questions about your treatment regimen.